Professional Summary

Professional Overview

Jeff Hermes is an accomplished executive with extensive experience in the pharmaceutical and biotech industries. As the Executive Vice President of Enabling Sciences at Odyssey Therapeutics, he oversees the development and implementation of innovative scientific platforms that drive the company's drug discovery and development efforts.

Experience Summary

Current Role

In his current role at Odyssey Therapeutics, Jeff is responsible for leading the Enabling Sciences team, which is instrumental in identifying and validating novel therapeutic targets, designing high-throughput screening campaigns, and advancing promising drug candidates through the preclinical pipeline. Under his leadership, the team has delivered significant breakthroughs, resulting in the progression of multiple programs into clinical development.

Career Progression

Prior to joining Odyssey Therapeutics, Jeff held several senior leadership positions at prominent pharmaceutical and biotech companies. As the Vice President and Head of In Vitro Pharmacology at Kallyope, he directed the company's efforts in developing innovative therapeutic approaches for metabolic and neurological disorders. Before that, he served as the President of Hermes Biosolutions LLC, a consulting firm specialized in advising clients on drug discovery and development strategies.

Jeff's extensive industry experience also includes his tenure at Roche, where he led the Screening and Translational Enzymology team, and his roles at Merck, where he served as the Executive Director and North Wales Site Head, as well as the Senior Director and Site Lead for the In Vitro Sciences team in Rahway.

Academic Background

Jeff holds a Ph.D. in Biochemistry from the University of California, Berkeley, where he conducted groundbreaking research on protein structure and function. His academic achievements and specialized expertise have been instrumental in shaping his successful career in the pharmaceutical and biotech industries.

Areas of Expertise

Jeff's areas of expertise include in vitro pharmacology, high-throughput screening, target validation, and the development of novel therapeutic modalities. He is also a skilled leader, adept at building and leading cross-functional teams to drive innovative research and development initiatives.

Professional Impact

Throughout his career, Jeff has made significant contributions to the advancement of drug discovery and development. His work has resulted in the successful advancement of multiple drug candidates, and he has a proven track record of collaborating with academic and industry partners to identify and validate new therapeutic targets.

Conclusion

With his extensive experience, deep scientific expertise, and proven leadership abilities, Jeff Hermes is poised to continue making a meaningful impact in the pharmaceutical and biotech industries. As the Executive Vice President of Enabling Sciences at Odyssey Therapeutics, he is well-positioned to guide the company's drug discovery and development efforts, helping to bring innovative therapies to patients in need.